REQUEST A DEMO
Total
USD $0.00
Search more companies

Healol Pharmaceuticals Sdn. Bhd. (Malaysia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Healol Pharmaceuticals Sdn. Bhd. Profile Updated: January 24, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

Healol Pharmaceuticals Sdn. Bhd. is an enterprise located in Malaysia, with the main office in Kuala Lumpur. It operates in the Drugs and Druggists' Sundries Merchant Wholesalers sector. The company was established on May 05, 1994. It currently has a total number of 101 - 500 (2024) employees. Over the same period, its total assets grew by 13.03%.

Headquarters
74-3, Jalan Wangsa Delima 6, Klsc, Wangsa Maju
Kuala Lumpur; Federal Territories; Postal Code: 53300

Contact Details: Purchase the Healol Pharmaceuticals Sdn. Bhd. report to view the information.

Website: http://www.healol.com

Basic Information
Total Employees:
Purchase the Healol Pharmaceuticals Sdn. Bhd. report to view the information.
Registered Capital:
Purchase the Healol Pharmaceuticals Sdn. Bhd. report to view the information.
Financial Auditors:
Purchase the Healol Pharmaceuticals Sdn. Bhd. report to view the information.
Incorporation Date:
May 05, 1994
Key Executives
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Secretary
Ownership Details
Purchase this report to view the information.
100%
Subsidiaries
Healol Biogen Sdn. Bhd.
100%
Healol Melaka Biotech Sdn. Bhd.
90%
Healol Bioceuticals Sdn. Bhd.
80%
Company Performance
Financial values in the chart are available after Healol Pharmaceuticals Sdn. Bhd. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency MYR. Absolute financial data is included in the purchased report.
Operating Profit
20.75%
EBITDA
20.75%
Net Profit/Loss for the Period
-11.62%
Total Assets
13.03%
Total Equity
7.39%
Return on Equity (ROE)
-5.46%
Quick Ratio
-0.72%
Cash Ratio
-0.56%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?